GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Cyclically Adjusted PB Ratio

Biofarm (BSE:BIO) Cyclically Adjusted PB Ratio : 2.02 (As of Jun. 02, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Biofarm Cyclically Adjusted PB Ratio?

As of today (2025-06-02), Biofarm's current share price is lei0.708. Biofarm's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was lei0.35. Biofarm's Cyclically Adjusted PB Ratio for today is 2.02.

The historical rank and industry rank for Biofarm's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSE:BIO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.53   Med: 1.99   Max: 2.55
Current: 2.02

During the past years, Biofarm's highest Cyclically Adjusted PB Ratio was 2.55. The lowest was 1.53. And the median was 1.99.

BSE:BIO's Cyclically Adjusted PB Ratio is ranked worse than
52.16% of 694 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs BSE:BIO: 2.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biofarm's adjusted book value per share data for the three months ended in Mar. 2025 was lei0.518. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is lei0.35 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofarm Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biofarm's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Cyclically Adjusted PB Ratio Chart

Biofarm Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.52 1.65 2.07 2.11

Biofarm Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.17 2.35 2.11 1.92

Competitive Comparison of Biofarm's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofarm's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biofarm's Cyclically Adjusted PB Ratio falls into.


;
;

Biofarm Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biofarm's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.708/0.35
=2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofarm's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Biofarm's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.518/134.9266*134.9266
=0.518

Current CPI (Mar. 2025) = 134.9266.

Biofarm Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.154 100.684 0.206
201509 0.160 100.392 0.215
201512 0.185 99.792 0.250
201603 0.191 100.470 0.257
201606 0.186 101.688 0.247
201609 0.194 101.861 0.257
201612 0.200 101.863 0.265
201703 0.209 102.862 0.274
201706 0.204 103.349 0.266
201709 0.213 104.136 0.276
201712 0.220 104.011 0.285
201803 0.232 105.290 0.297
201806 0.223 106.317 0.283
201809 0.237 106.507 0.300
201812 0.229 105.998 0.291
201903 0.245 107.251 0.308
201906 0.248 108.070 0.310
201909 0.260 108.329 0.324
201912 0.261 108.420 0.325
202003 0.280 108.902 0.347
202006 0.271 108.767 0.336
202009 0.287 109.815 0.353
202012 0.296 109.897 0.363
202103 0.319 111.754 0.385
202106 0.312 114.631 0.367
202109 0.330 115.734 0.385
202112 0.338 117.630 0.388
202203 0.365 121.301 0.406
202206 0.358 125.017 0.386
202209 0.380 125.227 0.409
202212 0.386 125.222 0.416
202303 0.418 127.348 0.443
202306 0.407 128.729 0.427
202309 0.427 129.860 0.444
202312 0.441 129.419 0.460
202403 0.462 131.776 0.473
202406 0.452 132.554 0.460
202409 0.484 133.029 0.491
202412 0.485 133.157 0.491
202503 0.518 134.927 0.518

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biofarm  (BSE:BIO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biofarm Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biofarm's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofarm Business Description

Industry
Traded in Other Exchanges
N/A
Address
99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.